Mortgage Rates Hold Steady After Early March Drop

By: Catherine Koh in Eye On Housing

(March 31, 2025) — Mortgage rates dropped significantly at the start of March before stabilizing, with the average 30-year fixed-rate mortgage settling at 6.65%, according to Freddie Mac. This marks a 19-basis-point (bps) decline from February. Meanwhile, the 15-year fixed-rate mortgage fell by 20 bps to 5.83%.

The drop in long-term borrowing costs was driven by a 24-bps decline in the 10-year Treasury yield, which averaged 4.28% in March. This decline provided a boost to the housing market—new home sales increased 5.1% year-over-year in February, while the participation of first-time homebuyer of existing homes rose 26% over the same period. However, existing home sales saw a slight dip from last February.

The decrease in Treasury yields reflects growing concerns about an economic slowdown, particularly as shifts in tariff policy weaken consumer confidence. Despite this, the labor market remained resilient in February, posting steady job gains even as the unemployment rate ticked up slightly. The strength of upcoming jobs reports will be critical in assessing whether recession risks are intensifying.

At the latest FOMC meeting, the Federal Reserve held interest rates steady but revised its 2025 economic projections: expected GDP growth was lowered to 1.7% (down from 2.1% in December 2024) and the projected unemployment rate was raised to 4.4%, up 0.1 percentage point from previous estimates.

Dashboard 1

 




Tucson Industrial Market Forecast 2025

 

By: Max Fisher, Industrial Properties Broker, BRD Realty

TUCSON, AZ (March 31, 2025) — The Tucson industrial real estate market shows signs of continued resilience amid broader national trends. Let’s take a closer look at the current state of Tucson’s industrial sector, focusing on vacancy rates, user and investor property values, increased sub-leasing, construction activity, major projects, and national industrial real estate trends that may influence the market.

Vacancy Rates: A Tight Market

Tucson’s industrial real estate market remains relatively tight, with vacancy rates hovering at historically low levels but higher than 2021-2023 levels. As of late 2024, vacancy for industrial properties in Tucson is around 5-6%, which has stayed relatively consistent over the past year. Most of this vacancy lies within the 100,000 SF + bay market. This reflects a broader trend seen in the Southwestern U.S, where demand for industrial space outpaces supply but demand for big bay has slowed.

Construction Activity: 1,000,000 SF +-

In 2024, more industrial square footage was demolished and redeveloped than built. Despite low vacancy rates, construction in the Tucson industrial real estate market has been increasing to meet demand. Developers have responded to the growing need for space by initiating several major projects, breaking ground in November 2024 and set to be completed in the second half of 2025. Around 1,000,000 SF of spec industrial is slated to be completed in 2025.

These projects are focused on the mid to larger bay size range. Small bay construction costs remain high and lease rates will have to double to justify new construction. While materials costs have dropped, labor costs continue to climb. Overall, construction costs have seemed to plateau.

Sub-Markets

The  Tucson Airport market is seeing significant growth in its industrial footprint, with expansions and new construction planned to accommodate air freight, e-commerce, and global supply chain operations. The airport’s proximity to the border makes it a valuable asset for cross-border trade, and its industrial infrastructure is poised for long-term growth. With the airport area in high demand, land is now scarce. This lack of vacant land in the airport market will push demand outward into areas like Marana and Vail. A few vacant parcels have already been purchased in the Ajo/Palo Verde market and will soon be developed, but large parcels of vacant industrial land are now scarce.
The Northwest/Marana market has the highest demand from small-mid-bay tenants and buyers. As much growth in retail and residential pushes into Marana, the most sought-after area in the Southern Arizona region, from retailers, consumers, and industrial businesses, while lease rates in the Northwest now push North of $1.00 NNN.

Picture

Picture

Demand Drivers

We expect demand to remain similar to 2024 trends, focusing on e-commerce, mining, defense, aerospace, and the ancillary businesses that support the multifamily and SFR new construction market.
One unexpected demand driver is redevelopment. While industrial space is highly sought after, retail and multifamily values are significantly higher. We will see further redevelopment demand, along with eminent domain demand, in the southern market as the state starts to expand I-10 near Country Club and add a new on/off ramp.

Sub-Leasing Increases

While vacancy remains low, we have seen distress from tenants over the past 18 months. This distress comes in the form of bankruptcies, defaults, and increased subleasing. Most of the distress stems from increases in materials and labor costs. Consumer demand remains mostly steady while dipping in some aspects of the economy. Think big-ticket items like furniture and outdoor improvements, for example.

User and Investor Pricing

The user market remains the strongest while the investor market trudges along with very low transaction volumes. We expect the user market to remain strong through 2025 as most of these buildings are less than 50,000 SF and this is the size range where vacancy is the lowest. User values are now even pushing $200 per square foot with the highest values in the less than 10,000 SF market and the warehouse with fenced yard market.

Despite fed rate cuts, the ten year treasury remains above 4.5% which means interest rates remain higher. Despite the cost of debt remaining high, there is plenty of demand and dry powder but the gap between buyer and seller expectations has remained too far apart for the past 2.5 years. In addition to the cost of debt, banks are underwriting in a much more conservative manner.

However, higher for longer may result in more transactions in 2025-2026 as 5 year loans mature and owners have to decide between selling or refinancing.

Max Fisher’s significant Q4 2024 transactions;

1455 W River – $3,850,000 Sale – Represented Buyer, Escalante Concrete – 20,000 SF
3970 S Evans Road – $1,725,000 Sale – Represented Buyer, Ninyo & Moore Geotechnical – 11,443 SF
4261 S Country Club – Represented Landlord, 420 Aviation LLC – 24,380 SF
6640 S Bonney – Represented Tenant, Sia Botanics – 9,240 SF
Total transaction volume for 2024 – 78 Leases & Sales



Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years

Investment builds on the almost 140-year legacy of improving and saving lives and supporting American jobs. Includes four planned new manufacturing facilities, with ground-breaking today in North Carolina on $2 billion+ facility – Total U.S. economic impact estimated to be more than $100 billion per year

(March 28, 2025) — Following the splashy releases from Eli LillyMerck & Co. and Amgen emphasizing their investments in U.S.-based manufacturing. Last week, Johnson & Johnson (NYSE: JNJ), healthcare’s leading, most comprehensive innovation powerhouse, announced manufacturing, research and development, and technology investments of more than $55 billion in the United States over the next four years. This represents a 25% increase in investment compared to the previous four years and builds upon the Company’s already elevated U.S. investment levels resulting from the passage of the 2017 Tax Cuts & Jobs Act.

“Today’s announcements accelerate our nearly 140-year legacy as an American innovation engine tackling the world’s toughest healthcare challenges,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “Our increased U.S. investment begins with the ground-breaking of a high-tech facility in North Carolina that will not only add U.S.-based jobs but manufacture cutting edge medicines to treat patients in America and around the world.”

$55 Billion Investment Supports American Innovation & Manufacturing

In addition to the facility in Wilson, North Carolina, the Company’s increased investment in the U.S. over the next four years includes:

  • Three new advanced manufacturing facilities and the expansion of several existing sites across the Company’s Innovative Medicine and MedTech businesses will create high-paying, high-technology jobs. The Company will share further information on these sites once available.
  • Significant investments in extensive R&D infrastructure aimed at developing lifesaving and life-changing treatments in oncology, neuroscience, immunology, cardiovascular disease, and robotic surgery.
  • Increased technology investments to help make drug discovery and development faster, support workforce training, and enhance our business operations.
  • With its increased investment over the next four years, the Company’s U.S. economic impact will build upon its already estimated more than $100 billion per year.

Groundbreaking in North Carolina Kickstarts U.S. Investment

The North Carolina investment creates jobs starting today in Wilson, North Carolina, where the Company is officially breaking ground on its new, 500,000 square foot, state-of-the-art biologics manufacturing facility.

The North Carolina facility will:

  • Expand our capacity to manufacture next-generation medicines for people living with cancer, immune-mediated and neurological diseases in America and around the world.
  • Support approximately 5,000 jobs during construction and create over 500 positions in North Carolina.
  • Create a $3 billion impact across the state in the first 10 years of operations.

Johnson & Johnson has more manufacturing facilities in the U.S. than in any other country and is a leading investor in American innovation and R&D. With a focus on pharmaceuticals and medical technology, the Company stands alone in its ability to impact the full spectrum of disease. From cardiology to cancer, mental health to vision, cell therapies to robotics, the depth and breadth of Johnson & Johnson’s expertise and capabilities is unique. No company can match Johnson & Johnson’s ability to deliver best-in-class solutions for patients at every step of their journeys.

PHOTO: The new $2 billion biologics manufacturing facility in Wilson, N.C., will span approximately 500,000 square feet. (Rendering courtesy of Johnson & Johnson)